Literature DB >> 7978790

Treatment of destructive arthritic disorders with MMP inhibitors. Potential role of tetracyclines.

R A Greenwald1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7978790     DOI： 10.1111/j.1749-6632.1994.tb24734.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  13 in total

Review 1.  Matrix metalloproteinase inhibitors.

Authors:  S M Wojtowicz-Praga; R B Dickson; M J Hawkins
Journal:  Invest New Drugs       Date:  1997       Impact factor: 3.850

Review 2.  Repurposing an old drug to improve the use and safety of tissue plasminogen activator for acute ischemic stroke: minocycline.

Authors:  David C Hess; Susan C Fagan
Journal:  Pharmacotherapy       Date:  2010-07       Impact factor: 4.705

3.  The OARSI histopathology initiative - recommendations for histological assessments of osteoarthritis in the guinea pig.

Authors:  V B Kraus; J L Huebner; J DeGroot; A Bendele
Journal:  Osteoarthritis Cartilage       Date:  2010-10       Impact factor: 6.576

4.  Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study.

Authors:  Liz M Leite; Antônio Germano G Carvalho; Pollyanna L F Tavares Ferreira; Igor Xavier Pessoa; Danilo O Gonçalves; Amanda de Araújo Lopes; Jean Guilherme dos Santos Góes; Victor Costa de Castro Alves; Luzia Kalyne A M Leal; Gerly Anne Brito; Glauce S B Viana
Journal:  Inflammopharmacology       Date:  2011-02-25       Impact factor: 4.473

Review 5.  Disease-modifying therapies for osteoarthritis : current status.

Authors:  Marc Fajardo; Paul E Di Cesare
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 6.  The clinical potential of matrix metalloproteinase inhibitors in the rheumatic disorders.

Authors:  S Elliott; T Cawston
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

7.  A novel mechanism of action of tetracyclines: effects on nitric oxide synthases.

Authors:  A R Amin; M G Attur; G D Thakker; P D Patel; P R Vyas; R N Patel; I R Patel; S B Abramson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-11-26       Impact factor: 11.205

8.  A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.

Authors:  Muzharul M Islam; Christopher D Franco; David W Courtman; Michelle P Bendeck
Journal:  Am J Pathol       Date:  2003-10       Impact factor: 4.307

9.  Evaluation of a magnetic resonance biomarker of osteoarthritis disease progression: doxycycline slows tibial cartilage loss in the Dunkin Hartley guinea pig.

Authors:  Jonathan Bowyer; Chris G Heapy; Joanne K Flannelly; John C Waterton; Rose A Maciewicz
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

10.  Effects of doxycycline on mesenchymal stem cell chondrogenesis and cartilage repair.

Authors:  Hannah H Lee; Michael J O'Malley; Nicole A Friel; Constance R Chu
Journal:  Osteoarthritis Cartilage       Date:  2012-11-24       Impact factor: 6.576
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.